EPICS Therapeutics

📍 Gosselies, Belgium🗓 Founded 2018👥 25 employees💰 Last funded Jan 2019
Biotechnology Research🌐 epicstherapeutics.com
Website LinkedIn
EPICS is a drug discovery and development company that invents and develops small molecule drugs targeting RNA epigenetic mechanisms involved in cancer development. EPICS’s mission is to utilize its expertise in drug discovery and development to invent novel clinical agents targeting serious unmet medical needs in oncology. We develop products to meet high value-added endpoints. We constantly balance risk and reward in determining if and when to partner our programs.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
2
Frequently asked questions
Who invested in EPICS Therapeutics?
EPICS Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did EPICS Therapeutics last raise funding?
The most recent investment in EPICS Therapeutics recorded on gritt.io was in January 2019.
When was EPICS Therapeutics founded?
EPICS Therapeutics was founded in 2018.
What industry is EPICS Therapeutics in?
EPICS Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is EPICS Therapeutics based?
EPICS Therapeutics is headquartered in Gosselies, Belgium.